Table 2: The Values of Cytokines at Baseline and After 6 Months of Anti-TNFa Treatment
|
Cytokines Value |
ADA Group
Week 0 |
ETN Group
Week 0 |
IFN Group
Week 0 |
ADA Group
Week 24 |
ETN Group
Week 24 |
IFN Group
Week 24 |
P
Value |
| TNFa pg/ml |
33.1±12.3 |
33.1±12.3 |
34.4±12.6 |
86.7±70.3 |
171.4±69.4 |
182.5±47.4 |
NS |
| IL-6 pg/ml |
6.7±3.5 |
7.6±2.9 |
7,1±3.1 |
8.8±2.7 |
4.7±3.5 |
6.4±4.3 |
NS |
| IL-10 pg/ml |
3.2±1.5 |
3.6±2.1 |
2.5±1.6 |
3.9±2.8 |
2.5±2.3 |
5.5±5.1 |
NS |
| IL-8 pg/ml |
4.8±2.1 |
3.7±2.1 |
4.1±1.9 |
3.03±2.1 |
5.8±4.1 |
4.7±2.9. |
NS |
| TNFa/IL10 ratio |
78.9±11.7 |
54.1±12.7 |
54.2±13.9. |
78.9±11.7 |
54.1±12.7 |
54.2±13.9 |
NS |